SCHEMBL3707683

SCHEMBL3707683

O=[N+]([O-])c1c(Cl)ccc2cc3ccccc3cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.59
TSHR P16473 4/20 0.45
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
VCAM1 P19320 1/20 0.40
HPRT1 P00492 1/20 0.40
CASP6 P55212 1/20 0.40
HSD17B10 Q99714 1/20 0.39
TNF P01375 1/20 0.38
NOD1 Q9Y239 1/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
RORC P51449 1/20 0.37
HNF4A P41235 1/20 0.37
CYP2A6 P11509 1/20 0.37
S100A4 P26447 1/20 0.37
PIN1 Q13526 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3782714 0.98 CYP3A4 (0.58) CYP3A4TSHRALDH1A1TDP1VCAM1
SCHEMBL3704204 0.98 CYP3A4 (0.58) CYP3A4TSHRALDH1A1TDP1VCAM1
SCHEMBL3699674 0.84 TSHR (0.62) CYP3A4TSHRALDH1A1TDP1HPRT1
SCHEMBL122680 0.81 CYP3A4 (0.61) CYP3A4TSHRALDH1A1TDP1HPRT1
SCHEMBL3776997 0.79 HPRT1 (0.56) CYP3A4TSHRALDH1A1TDP1HPRT1
SCHEMBL3697120 0.79 HPRT1 (0.56) CYP3A4TSHRALDH1A1TDP1HPRT1
SCHEMBL8982533 0.79 CYP3A4 (0.59) CYP3A4TSHRALDH1A1TDP1HPRT1
SCHEMBL10719531 0.79 CYP3A4 (0.59) CYP3A4TSHRTDP1HPRT1CASP6
SCHEMBL27665520 0.76 CYP3A4 (0.64) CYP3A4TSHRALDH1A1TDP1HPRT1
SCHEMBL29660190 0.76 CYP3A4 (0.59) CYP3A4TSHRALDH1A1TDP1HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2460789-B1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL CO (JP) 2017-04-19 EP disclosed
US-9079830-B2 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-14 US disclosed
EP-2460789-A1 METHOD FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2012-06-06 EP disclosed
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND AKR7A2, AOC2, CBR1 CYP3A4 219/4885TSHR 1160/4885ALDH1A1 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.